Komori
Revision to earnings forecasts4204Sekisui Chemical Co.,Ltd.Materials and Chemicals

Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)

Raised the forecasts for full-year consolidated net sales, operating income and ordinary income for the fiscal year ending March 2027, while leaving net income attributable to owners of the parent unchanged. The interim dividend was increased by ¥1, and the full-year dividend forecast was also raised from ¥81 to ¥82.

Worth reading
65In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
7
% (change rates for operating profit and ordinary profit)
Wording
Avoiding a definitive answer
How definitive the wording is.

Revised forecast

Fiscal year ending March 2027 · Full yearPrevious forecast published Published on 28 April 2026
Net Sales1,408,400→1,491,000million
+5.9%
Operating profit115,000→123,000million
+7.0%
Ordinary income114,000→122,000million
+7.0%
Profit attributable to owners of the parent76,000→76,000million
0.0%
Net income per share188.26→188.17Yen/sen
-0.0%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

Although market conditions remain uncertain and some reaction to the pull-forward of demand in the interim period is expected, earnings are projected to exceed the initial forecast due to factors including the maintenance of spreads and improved profitability from expanding sales of high-value-added products.

Details and amount of extraordinary loss

Costs for the replacement of specified products: ¥5,143 million; business structure improvement expenses: ¥2,604 million; losses on the disposal and sale of fixed assets: ¥1,235 million; impairment losses: ¥521 million; valuation losses on investment securities: ¥211 million; losses on the sale of investment securities: ¥3 million. Total extraordinary losses: ¥9,718 million.

Previous-period resultsNet sales: ¥1,309,281 million; operating income: ¥106,477 million; ordinary income: ¥117,215 million; net income attributable to owners of the parent: ¥75,174 million; net income per share: ¥182.70
Dividend forecast revisionThe second-quarter-end dividend was increased by ¥1 from ¥40.00 to ¥41.00, and the annual dividend was increased by ¥2 from ¥81.00 to ¥82.00.
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales¥1,408,400 million → ¥1,491,000 million(+5.9%)
Operating profit¥115,000 million → ¥123,000 million(+7.0%)
Ordinary income¥114,000 million → ¥122,000 million(+7.0%)
Profit attributable to owners of the parent¥76,000 million → ¥76,000 million(0.0%)
Net income per share188.26 Yen/sen → 188.17 Yen/sen
Fiscal Period CoveredFiscal year ending March 2027
Period CoveredFull year
Publication date of previous forecastPublished on 28 April 2026
Previous-period resultsNet sales: ¥1,309,281 million; operating income: ¥106,477 million; ordinary income: ¥117,215 million; net income attributable to owners of the parent: ¥75,174 million; net income per share: ¥182.70
Reason for the revisionAlthough market conditions remain uncertain and some reaction to the pull-forward of demand in the interim period is expected, earnings are projected to exceed the initial forecast due to factors including the maintenance of spreads and improved profitability from expanding sales of high-value-added products.
Details and amount of extraordinary lossCosts for the replacement of specified products: ¥5,143 million; business structure improvement expenses: ¥2,604 million; losses on the disposal and sale of fixed assets: ¥1,235 million; impairment losses: ¥521 million; valuation losses on investment securities: ¥211 million; losses on the sale of investment securities: ¥3 million. Total extraordinary losses: ¥9,718 million.
Dividend forecast revisionThe second-quarter-end dividend was increased by ¥1 from ¥40.00 to ¥41.00, and the annual dividend was increased by ¥2 from ¥81.00 to ¥82.00.
Consolidated / non-consolidatedConsolidated

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Although market conditions remain uncertain and some reaction to the pull-forward of demand in the interim period is expected, earnings are projected to exceed the initial forecast due to factors including the maintenance of spreads and improved profitability from expanding sales of high-value-added products.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated) | Sekisui Chemical Co.,Ltd. (4204) timely disclosure | Komori